We show that CO can be converted by an engineered "Knallgas" bacterium (Cupriavidus necator) into the terpene α-humulene. Heterologous expression of the mevalonate pathway and α-humulene synthase resulted in the production of approximately 10 mg α-humulene per gram cell dry mass (CDW) under heterotrophic conditions. This first example of chemolithoautotrophic production of a terpene from carbon dioxide, hydrogen, and oxygen is a promising starting point for the production of different high-value terpene compounds from abundant and simple raw materials. Furthermore, the production system was used to produce 17 mg α-humulene per gram CDW from CO and electrical energy in microbial electrosynthesis (MES) mode. Given that the system can convert CO by using electrical energy from solar energy, it opens a new route to artificial photosynthetic systems.
We show that CO 2 can be converted by an engineered "Knallgas" bacterium (Cupriavidus necator) into the terpene a-humulene.H eterologous expression of the mevalonate pathwaya nd a-humulene synthase resulted in the production of approximately 10 mg a-humulene per gram cell dry mass (CDW) under heterotrophic conditions.T his first example of chemolithoautotrophic production of at erpene from carbon dioxide,h ydrogen, and oxygen is ap romising starting point for the production of different high-value terpene compounds from abundant and simple raw materials.F urthermore,the production system was used to produce 17 mg ahumulene per gram CDWf rom CO 2 and electrical energy in microbial electrosynthesis (MES) mode.Given that the system can convert CO 2 by using electrical energy from solar energy,it opens anew route to artificial photosynthetic systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.